Your browser doesn't support javascript.
loading
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.
Merseburger, Axel S; Attard, Gerhardt; Åström, Lennart; Matveev, Vsevolod B; Bracarda, Sergio; Esen, Adil; Feyerabend, Susan; Senkus, Elzbieta; López-Brea Piqueras, Marta; Boysen, Gunther; Gourgioti, Georgia; Martins, Karla; Chowdhury, Simon.
Afiliación
  • Merseburger AS; Department of Urology, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany. Electronic address: axel.merseburger@uksh.de.
  • Attard G; Department of Oncology, University College London Cancer Institute, London, UK.
  • Åström L; Department of Immunology, Genetics and Pathology, University of Uppsala, Uppsala, Sweden.
  • Matveev VB; Department of Urology, Blokhin Cancer Research Center, Moscow, Russia.
  • Bracarda S; Medical Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Esen A; Department of Urology, Dokuz Eylul University, Konak, Türkiye.
  • Feyerabend S; Studienpraxis Urologie, Nürtingen, Germany.
  • Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • López-Brea Piqueras M; Department of Medical Oncology, Marqués de Valdecilla University Hospital, Cantabria, Spain.
  • Boysen G; Medical Affairs, Astellas Pharma Europe, Addlestone, UK.
  • Gourgioti G; Medical Affairs, Astellas Pharma Europe, Addlestone, UK.
  • Martins K; Medical Affairs, Astellas Pharma Europe, Addlestone, UK.
  • Chowdhury S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Lancet Oncol ; 23(11): 1398-1408, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36265504

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article